Anti-tachycardia pacing control in an implantable medical device system
An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.
1 . A medical device comprising:
a sensing circuit configured to receive a cardiac electrical signal;
a therapy delivery circuit coupled to the control circuit, the therapy delivery circuit comprising a high voltage capacitor chargeable to a shock voltage amplitude for delivering a cardioversion/defibrillation shock pulse;
a control circuit coupled to the sensing circuit and the therapy delivery circuit and configured to:
detect a tachyarrhythmia from the cardiac electrical signal;
start an anti-tachycardia pacing (ATP) therapy delay period in response to detecting the tachyarrhythmia to delay an ATP therapy;
compare a charge of the high voltage capacitor to a threshold voltage;
in response to the charge of the high voltage capacitor meeting the threshold voltage, cancel the delayed ATP therapy; and
in response to the charge of the high voltage capacitor not meeting the threshold voltage, control the therapy delivery circuit to adjust the charge of the high voltage capacitor to a pacing voltage amplitude during the ATP therapy delay period.
2 . The medical device of claim 1 wherein:
the control circuit is further configured to:
determine a synchronization interval based on the detected tachyarrhythmia;
determine one or more RR intervals from the cardiac electrical signal sensed during the ATP therapy delay period;
determine whether ATP therapy delivery criteria are met based on the synchronization interval and the one or more RR intervals; and
the therapy delivery circuit is configured to:
deliver the delayed ATP therapy when the ATP therapy delivery criteria are met; and
cancel the delayed ATP therapy when the ATP therapy delivery criteria are not met.
3 . The medical device of claim 1 wherein the control circuit is further configured to, when the delayed ATP therapy is canceled:
advance to a next therapy in a menu of therapies programmed in the medical device for treating the detected tachyarrhythmia; and
control the therapy delivery circuit to deliver the next therapy.
4 . The medical device of claim 1 wherein the therapy delivery circuit is further configured to charge the high voltage capacitor from the charge of the high voltage capacitor to a shock voltage amplitude when the delayed ATP therapy is cancelled.
5 . The medical device of claim 1 wherein the therapy delivery circuit is further configured to deliver a cardioversion/defibrillation shock pulse when the delayed ATP therapy is canceled.
6 . The medical device of claim 1 wherein the control circuit is further configured to compare the charge of the high voltage capacitor to the threshold voltage by comparing the charge of the high voltage capacitor to a pacing voltage amplitude plus a charge difference.
7 . The medical device of claim 4 wherein the control circuit is further configured to compare the charge of the high voltage capacitor to the threshold voltage where the threshold voltage is up to forty volts.
8 . The medical device of claim 1 wherein the control circuit is further configured to compare the charge of the high voltage capacitor to the threshold voltage by comparing the charge of the high voltage capacitor to one of a percentage of a pacing voltage amplitude or a percentage of a shock voltage amplitude.
9 . The medical device of claim 1 wherein the control circuit is further configured to:
compare the charge of the high voltage capacitor to the threshold voltage by:
determining a difference between the charge of the high voltage capacitor and the threshold voltage;
determining an estimated charge adjustment time based on the determined difference; and
comparing the estimated charge adjustment time to an acceptable therapy delay time; and
determine that the charge of the high voltage capacitor does not meet the threshold voltage when the estimated charge adjustment time is less than the acceptable therapy delay time.
10 . The medical device of claim 1 wherein the therapy delivery circuit is further configured to adjust the charge of the high voltage capacitor to the pacing voltage amplitude that is at least a pacing capture threshold of an extra-cardiovascular pacing electrode vector when the charge of the high voltage capacitor does not meet the threshold voltage.
11 . A method comprising:
receiving a cardiac electrical signal;
detecting a tachyarrhythmia from the cardiac electrical signal;
starting an anti-tachycardia pacing (ATP) therapy delay period in response to detecting the tachyarrhythmia to delay an ATP therapy;
comparing a charge of a high voltage capacitor to a threshold voltage, the high voltage capacitor chargeable to a shock voltage amplitude for delivering a cardioversion/defibrillation shock pulse;
in response to the charge of the high voltage capacitor meeting the threshold voltage, cancelling the delayed ATP therapy; and
in response to the charge of the high voltage capacitor not meeting the threshold voltage, adjusting the charge of the high voltage capacitor to a pacing voltage amplitude during the ATP therapy delay period.
12 . The method of claim 1 further comprising:
determining a synchronization interval based on the detected tachyarrhythmia;
determining one or more RR intervals from the cardiac electrical signal sensed during the ATP therapy delay period;
determining whether ATP therapy delivery criteria are met based on the synchronization interval and the one or more RR intervals;
delivering the delayed ATP therapy when the ATP therapy delivery criteria are met; and
cancelling the delayed ATP therapy when the ATP therapy delivery criteria are not met.
13 . The method of claim 1 further comprising:
when the delayed ATP therapy is canceled, advancing to a next therapy in a menu of programmed therapies for treating the detected tachyarrhythmia; and
delivering the next therapy.
14 . The method of claim 11 further comprising charging the high voltage capacitor from the charge of the high voltage capacitor to a shock voltage amplitude when the delayed ATP therapy is cancelled.
15 . The method of claim 11 further comprising delivering a cardioversion/defibrillation shock pulse when the delayed ATP therapy is canceled.
16 . The method of claim 11 further comprising comparing the charge of the high voltage capacitor to the threshold voltage by comparing the charge of the high voltage capacitor to a pacing voltage amplitude plus a charge difference.
17 . The method of claim 11 further comprising comparing the charge of the high voltage capacitor to the threshold voltage where the threshold voltage is up to forty volts.
18 . The method of claim 11 further comprising comparing the charge of the high voltage capacitor to the threshold voltage by comparing the charge of the high voltage capacitor to one of a percentage of a pacing voltage amplitude or a percentage of a shock voltage amplitude.
19 . The method of claim 11 further comprising:
comparing the charge of the high voltage capacitor to the threshold voltage by:
determining a difference between the charge of the high voltage capacitor and the threshold voltage;
determining an estimated charge adjustment time based on the determined difference; and
comparing the estimated charge adjustment time to an acceptable therapy delay time; and
determining that the charge of the high voltage capacitor does not meet the threshold voltage when the estimated charge adjustment time is less than the acceptable therapy delay time.
20 . The method of claim 11 further comprising adjusting the charge of the high voltage capacitor to the pacing voltage amplitude that is at least a pacing capture threshold of an extra-cardiovascular pacing electrode vector when the charge of the high voltage capacitor does not meet the threshold voltage.
21 . A non-transitory computer readable medium storing a set of instructions that, when executed by a control circuit of a medical device, cause the medical device to:
receive a cardiac electrical signal;
detect a tachyarrhythmia from the cardiac electrical signal;
start an anti-tachycardia pacing (ATP) therapy delay period in response to detecting the tachyarrhythmia to delay an ATP therapy;
compare a charge of a high voltage capacitor to a threshold voltage, the high voltage capacitor chargeable to a shock voltage amplitude for delivering a cardioversion/defibrillation shock pulse;
in response to the charge of the high voltage capacitor meeting the threshold voltage, cancel the delayed ATP therapy; and
in response to the charge of the high voltage capacitor not meeting the threshold voltage, adjust the charge of the high voltage capacitor to a pacing voltage amplitude during the ATP therapy delay period.